Get App Open
In App
Lending
Lending
Open App
Success
Alert
Please select a Day.
Info

Kobo Biotech Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE

2.31
-0.12 (-4.94%)

As on 04 Dec, 2025 | 04:01

Day Range
2.31
2.43
L H
52 Week Range
2.08
4.56
L H
Volume
56,859
*
i

* BSE Market Depth (04 Dec 2025)

BUY SELL
QTY PRICE PRICE QTY
1999 2.31 2.35 597
0 0.00 2.37 1001
0 0.00 2.39 1
0 0.00 2.40 1
0 0.00 2.42 27
0 Total Total 0
Bid / Ask
2.31 / 2.35
NSE
MC Essentials
40% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Stock not eligible for rating

Financials
    Ownerships
      Industry Comparison
        Others
          Open 0.00
          Previous Close 0.00
          Volume 0.00
          Value (Lacs) 0.00
          VWAP 0.00
          Beta
          Mkt Cap (Rs. Cr.) 0
          High 0.00
          Low 0.00
          UC Limit 0.00
          LC Limit 0.00
          52 Week High 0.00
          52 Week Low 0.00
          Face Value 0.00
          All Time High 0.00
          All Time Low 0.00
          20D Avg Volume 0
          20D Avg Delivery(%) --
          Book Value Per Share --
          Dividend Yield --
          TTM EPS See historical trend 0.00
          TTM PE See historical trend --
          P/B See historical trend --
          Sector PE 0.00

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          Stock not eligible for rating

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 49.34% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Below Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 44.95% in Mar 2024 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          11 out of 16 years Kobo Biotech has given positive returns in December.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          December 110.19% (2019) 38.38% -26.19% (2022) -14.61% 21.82%

          News

          Forum

          Community Sentiments

          • 0% BUY
          • 100% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend selling Avon Life

          What's your call on Avon Life today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          No Data For Bulk Deals.

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Kobo Biotech 2.31 -4.94 5.50 - - 0.00 -19.79 -4 0 -1.05
          Sun Pharma 1,818.30 0.64 436,271.08 41.75 6.04 15.13 1.01 10,980 52,578 0.03
          Divis Labs 6,469.00 0.22 171,731.62 69.11 11.47 14.63 3.40 2,191 9,360 0.00
          Torrent Pharma 3,795.70 2.01 128,463.74 60.03 17.12 25.17 13.21 1,911 11,516 0.40
          Cipla 1,521.00 0.86 122,862.00 22.58 3.94 16.90 1.34 5,291 27,547 0.00

          About the Company

          Avon Organics Ltd is engaged in the production of Diketene which is the basic unit for hundreds of derivatives in pesticides, chemicals, pharmaceuticals and dyestuffs. The company`s product range includes Diketene:i.e.Pharmaceutical intermediates,Agrochemical intermediates & Pigment intermediates ; Pharmaceutical (Including Ephedrines):Active Pharmaceutical ingredients,Pharma intermediates & Formulation intermediates.
          {"success":1,"data":{"address":{"address1":"Plot No. 121A\/1,","address2":"Western Hills,,Addagutta Society, Opp. JNTU,","city":"Hyderabad","state":"Telangana","pincode":"500072","telephone1":"","telephone2":"","fax1":"040-","fax2":"","email":"info@avonlifesciences.com","web":"http:\/\/kobobiotech.com"},"management":[{"name":"Ajit Kamath","designation":"Chairman & Non-Exe.Director"},{"name":"Rajendra Kaimal","designation":"Non Executive Director"},{"name":"Sunil Pitroda","designation":"Independent Director"},{"name":"Abhishek Buddhadev","designation":"Independent Director"},{"name":"Urja Shah","designation":"Independent Director"}],"registrars":{"name":"XL Softech Systems Ltd.","address1":"No. 3, Sagar View Society,","address2":"Road No. 2,,","address3":"Banjara Hills,","address4":"","telephone":"040-23545913, 23545914, 23545915","fax":"040-23553214","email":"xlsoftech@hdl.vsnl.net.in","internet":"http:\/\/www.xlsoftech.com","city":"Hyderabad","state":"Telangana","pincode":"500034"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"531541","nseId":"","series":"","isinid":"INE881A01015"}}}
          • Registered Office

          • Registrars

          • Management

            • Ajit Kamath

              Chairman & Non-Exe.Director

            • Rajendra Kaimal

              Non Executive Director

            • Sunil Pitroda

              Independent Director

            • Abhishek Buddhadev

              Independent Director

            • Urja Shah

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              531541

            • NSE:

            • Series

            • ISIN

              INE881A01015

          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
          Close Gen AI Masterclass